IRIDEX (IRIX) Competitors $1.65 -0.01 (-0.60%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends IRIX vs. SRTS, ECOR, FONR, LNSR, GUTS, MLSS, MGRM, EDAP, STIM, and HYPRShould you be buying IRIDEX stock or one of its competitors? The main competitors of IRIDEX include Sensus Healthcare (SRTS), electroCore (ECOR), FONAR (FONR), LENSAR (LNSR), Fractyl Health (GUTS), Milestone Scientific (MLSS), Monogram Orthopaedics (MGRM), Edap Tms (EDAP), Neuronetics (STIM), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry. IRIDEX vs. Sensus Healthcare electroCore FONAR LENSAR Fractyl Health Milestone Scientific Monogram Orthopaedics Edap Tms Neuronetics Hyperfine Sensus Healthcare (NASDAQ:SRTS) and IRIDEX (NASDAQ:IRIX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, institutional ownership, earnings, valuation, dividends, profitability and media sentiment. Does the MarketBeat Community prefer SRTS or IRIX? IRIDEX received 90 more outperform votes than Sensus Healthcare when rated by MarketBeat users. However, 68.42% of users gave Sensus Healthcare an outperform vote while only 64.30% of users gave IRIDEX an outperform vote. CompanyUnderperformOutperformSensus HealthcareOutperform Votes18268.42% Underperform Votes8431.58% IRIDEXOutperform Votes27264.30% Underperform Votes15135.70% Which has more volatility & risk, SRTS or IRIX? Sensus Healthcare has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500. Comparatively, IRIDEX has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500. Is SRTS or IRIX more profitable? Sensus Healthcare has a net margin of 22.54% compared to IRIDEX's net margin of -22.79%. Sensus Healthcare's return on equity of 17.99% beat IRIDEX's return on equity.Company Net Margins Return on Equity Return on Assets Sensus Healthcare22.54% 17.99% 16.26% IRIDEX -22.79%-192.95%-33.97% Which has better valuation & earnings, SRTS or IRIX? Sensus Healthcare has higher earnings, but lower revenue than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSensus Healthcare$41.31M2.71$490K$0.5712.00IRIDEX$51.87M0.53-$9.57M-$0.67-2.46 Do institutionals and insiders believe in SRTS or IRIX? 25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 9.4% of Sensus Healthcare shares are held by company insiders. Comparatively, 7.3% of IRIDEX shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media refer more to SRTS or IRIX? In the previous week, Sensus Healthcare and Sensus Healthcare both had 1 articles in the media. Sensus Healthcare's average media sentiment score of 0.95 beat IRIDEX's score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sensus Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IRIDEX 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend SRTS or IRIX? Sensus Healthcare currently has a consensus target price of $12.50, suggesting a potential upside of 82.75%. IRIDEX has a consensus target price of $2.00, suggesting a potential upside of 21.21%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, research analysts clearly believe Sensus Healthcare is more favorable than IRIDEX.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33IRIDEX 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummarySensus Healthcare beats IRIDEX on 16 of the 18 factors compared between the two stocks. Get IRIDEX News Delivered to You Automatically Sign up to receive the latest news and ratings for IRIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRIX vs. The Competition Export to ExcelMetricIRIDEXElectromedical equipment IndustryComputer SectorNASDAQ ExchangeMarket Cap$27.46M$3.55B$26.70B$9.13BDividend YieldN/A1.66%2.74%4.00%P/E Ratio-2.4618.41236.3517.53Price / Sales0.5371.923,630.4380.47Price / CashN/A39.0935.9232.90Price / Book2.803.978.614.69Net Income-$9.57M$94.49M$670.02M$224.57M7 Day Performance2.29%6.53%4.08%3.33%1 Month Performance0.61%5.65%7.01%5.33%1 Year Performance-40.65%3.56%27.62%22.97% IRIDEX Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRIXIRIDEX0.5682 of 5 stars$1.65-0.6%$2.00+21.2%-40.3%$27.46M$51.87M-2.46120Analyst ForecastNews CoverageSRTSSensus Healthcare3.438 of 5 stars$6.44-1.5%$12.50+94.1%+151.3%$105.55M$41.31M11.3040News CoverageECORelectroCore3.402 of 5 stars$15.65-5.4%$25.00+59.7%+139.8%$102.59M$23.33M-8.5550FONRFONAR1.3193 of 5 stars$15.27+0.3%N/A-20.2%$96.63M$102.01M10.91480Short Interest ↑LNSRLENSAR0.8381 of 5 stars$8.19-0.7%$8.00-2.3%+133.1%$95.13M$48.87M-5.61110Positive NewsGUTSFractyl Health1.6781 of 5 stars$1.94+4.6%$22.00+1,036.8%N/A$93.08M$97,000.00-0.16102Positive NewsGap UpHigh Trading VolumeMLSSMilestone Scientific0.3824 of 5 stars$1.13-4.2%$1.25+10.6%+96.7%$88.02M$8.88M-16.1430Analyst ForecastNews CoverageMGRMMonogram Orthopaedics3.5095 of 5 stars$2.41-3.6%$4.00+66.0%-19.2%$82.69M$364,999.00-5.1328Positive NewsEDAPEdap Tms3.4674 of 5 stars$2.10flat$19.00+804.8%-64.5%$77.92M$63.41M-3.23307Gap UpSTIMNeuronetics2.9922 of 5 stars$2.40+40.4%$4.67+94.4%-25.9%$72.84M$72.71M-1.95180News CoveragePositive NewsHigh Trading VolumeHYPRHyperfine2.0168 of 5 stars$0.99+5.4%$1.60+61.6%+2.0%$72.21M$13.26M-1.74190 Related Companies and Tools Related Companies SRTS Alternatives ECOR Alternatives FONR Alternatives LNSR Alternatives GUTS Alternatives MLSS Alternatives MGRM Alternatives EDAP Alternatives STIM Alternatives HYPR Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IRIX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IRIDEX Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share IRIDEX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
